Advertisement
Analyst Looks At Odds Of Biogen Takeover
ResumeAfter a jump in its stock price of more than 9 percent on Tuesday, stock in Biogen, the Cambridge-based biotech giant, fell nearly 3 percent in trading on Wednesday.
The roller coaster follows a Wall Street Journal report this week that Biogen could be a takeover target. Biogen leadership is not commenting.
Peter Cohan, visiting lecturer on strategy and entrepreneurship at Babson College, joined Morning Edition to discuss
This segment aired on August 4, 2016.